| FDA NEWS FDA approves Trulicity to treat type 2 diabetes FDA committee recommends approval for liraglutide as anti-obesity drug |
 |
Medicare Part B Overpays Pharmacists to Dispense and Supply Drugs: Study
Wall Street Journal - September 16, 2014
A new report from the Office of the Inspector General in the U.S. Department of Health and Human Services finds that dispensing and supplying fees paid by the Medicare Part B program to retail pharmacies in 2011 were significantly higher than those paid by two other government health care programs – Medicare Part D and Medicaid.
Can Cheap Generic Statins Save Money and Lives? A Study Says ‘Yes!’
Wall Street Journal - September 16, 2014
A new study finds patients who had a lower co-payment for a generic statin were not only more likely to take their medicine, but they were also more likely to experience fewer deaths due to heart attack or stroke than those taking a brand-name statin.
8% of patients stop taking Sovaldi, CVS study finds
Modern Healthcare - September 17, 2014
The findings raise questions about how effective the costly drug will be in a larger patient population outside of a controlled clinical trial.
Blood Test Spots Adult Depression: Study
HealthDay News - September 16, 2014
A new blood test is the first objective scientific way to diagnose major depression in adults, a new study claims.
Combo Therapy Best for COPD: Study
HealthDay News - September 16, 2014
Researchers found two-drug regimen cut death, hospitalization rates for the respiratory disease.
Experts Want Limits on Testosterone Drug Use
Associated Press - September 18, 2014
U.S. health experts said Wednesday there is little evidence that testosterone-boosting drugs are effective for treating common signs of aging in men and that their use should be narrowed to exclude millions of Americans currently taking them.
EASD: Insulin Pumps Reduce Mortality, Fatal CVD Risk
HealthDay News - September 17, 2014
Significant reductions in the risk of all-cause mortality, fatal CVD risk with pump versus injections.
Obama directs federal agencies to ramp up efforts to deal with antibiotic resistance
Washington Post - September 18, 2014
After years of warnings from the science and medical communities about the depletion of the world’s arsenal of effective antibiotics, President Obama directed federal agencies Thursday to significantly ramp up their efforts to deal with the threat.
Antipsychotics for Dementia: CMS Says Use Less
MedPage Today - September 22, 2014
The Centers for Medicare & Medicaid Services (CMS) and other healthcare organizations are aiming to have use of antipsychotics among dementia patients decreased by 30% in the next 2 years.
Diabetes Drug Metformin May Affect Thyroid in Some Patients
HealthDay News - September 22, 2014
Medicine tied to lower thyroid-stimulating hormone levels in those with underactive thyroid.
A Bill Would Speed DEA Listings for Controlled Substances
Wall Street Journal - September 22, 2014
For the second time this year, a bill has been introduced in Congress to streamline the process used by the U.S. Drug Enforcement Agency to place prescription drugs that are controlled substances on a list of medicines for which distribution is restricted.
Should hospitals merge to improve care, lower costs?
Becker's Hospital Review - September 16, 2014
In a recent Wall Street Journal opinion piece, Kenneth L. Davis, MD, president and CEO of Mount Sinai Health System in New York City, discussed stand-alone hospitals and why they are unable to thrive in the new healthcare environment.
Cancer-fighting cocktail demonstrates promising results as treatment for advanced cervical cancer
ScienceDaily - September 16, 2014
Combining a standard chemotherapy drug with a second drug that stops cells from dividing improves both the survival and response rates for those with advanced cervical cancer, a new study finds.
Three part series- The price of pain: High costs spur questions about compound creams
89.3 KPCC Southern California Public Radio - September 10, 2014
Los Angeles workers’ compensation attorney Steven Alves is reviewing a case on his desk, trying to figure out why a tube of pain cream costs more than a car payment
Contact,
Kristin LaVitola
Marketing Director, PSG
Pharmaceutical Strategies Group (PSG)
Office: 972-244-8388
Email: KLavitola@PSGConsults.com
PSGNewsletter@PSGConsults.com
www.PSGConsults.com
 |
 |
 |